Want to contact a District of Columbia Sustiva lawyer? ...Get a free case evaluation from one of our District of Columbia Sustiva lawyers now.

Sustiva - MSN Newsfeeds

Heart disease and antiretroviral therapy
Aidsmap - These patients were 2.5 times more likely to have high blood pressure than patients taking efavirenz ( Sustiva ), although this seemed to be secondary to the drug's effect of increasing body mass index. A similar effect was seen with tenofovir (Viread ...
Access to treatment: treatment literacy
Aidsmap - Click on `Counselling and patient materials` for drug recognition charts in English and Xhosa developed for use with the regimens used in the Western Cape - d4T/3TC/nevirapine, d4T/3TC/efavirenz and AZT/ddI/lopinavir - and adherence/side effect ...
96-Week Data From Gilead's Study 934 Comparing Viread(R) and
MSN MoneyCentral - This study compares a once-daily regimen of Viread(R) (tenofovir disoproxil fumarate), Emtriva(R) (emtricitabine) and Sustiva(R) (efavirenz) to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva once daily. The study ...
Rallies, condom carnival as world marks AIDS Day
Domican Today - Thailand has also announced it will break the patent on Merck's HIV/AIDS drug Efavirenz to allow access to the live-saving drug at a lower price. In neighbouring Bangladesh, thousands of people including sex workers and others diagnosed with HIV/AIDS ...
FDA Approves Once-Daily Combo Drug for HIV
WXIX - The drug, called Atripla, combines Viread (tenofovir), Emtriva (emtricitabine) and Sustiva (efavirenz), to keep the human immunodeficiency virus under control. Viread and Emtriva are made by Gilead Sciences and are already sold in combination under ...
Cost Of AIDS Care Skyrockets
365 Gay - For example, a typical regimen for an HIV patient beginning treatment includes the drug efavirenz, which blocks a certain protein that HIV needs to make copies of itself. It also includes tenofovir and emtricitabine or some similar drug which ...
Sustiva may mess with your head
Gay.com UK - A small study in Australia has found that patients taking the drug efavirenz (Sustiva®) experience significantly more stress and anxiety than patients not taking the drug, even if they have been taking it for over six months. The study, though small ...
Click to Enlarge
Union - As part of her drug regimen, she began taking something called Sustiva. While it works for some, decreasing the virus load in their body and increasing the all important t-cells that build disease immunity, for others like Bojorquez it can cause ...
Bristol-Myers charity promo sparks reaction
Bridgeton News - Last week, for instance, Merck became embroiled with the Thailand government, which announced plans to issue a license to a state- owned drugmaker to maker a cheaper version of Sustiva. The drug is actually made by Bristol- Myers Squibb, which sells ...
FDA Clears New HIV Drug
Street.Com - Atripla combines Sustiva from Bristol-Myers Squibb and Truvada from Gilead. Truvada is itself a combination pill, containing Gilead's Viread and Emtriva. The companies say Atripla should improve patient compliance thanks to simplified dosing. The ...
South Africa: Scientists Warn State-Supplied Aids Drug Poses Diabetes ...
AllAfrica.com - The drug is one of three provided to patients in SA as "first-line therapy", along with lamivudine (3TC) and nevirapine or efavirenz. If patients develop severe side-effects or resistance, they switch to "second-line therapy", based on zidovudine (AZT ...
Thai ministry OKs AIDS drug patent license
Xinhua News Agency - BEIJING, Dec. 6 (Xinhuanet) -- Thailand's public health ministry announced Wednesday it will issue a compulsory license for a patent held by the Merck pharmaceutical company for the AIDS treatment drug efavirenz. Thailand is developing its own ...
Obsession with lower cost leads to deadly mistake
Bangkok Post - The manufacturer of the targetted drug, Efavirenz (sold as Stocrin), has now cut the price sharply, which sounds deceptively like good news. But as pressures grow on the companies that invested vast amounts of time and skill in developing drugs, they ...
Thai Health Ministry To Issue Compulsory License For Merck's HIV/AIDS ...
Medical News Today - Thailand's Ministry Of Public Health on Wednesday announced plans to issue a compulsory license to produce a lower-cost version of Merck 's antiretroviral drug Efavirenz, Reuters reports. World Trade Organization regulations allow governments to ...
Thailand issues license to manufacture generic version of Efavirenz ...
NewsTarget - (NewsTarget) Thailand announced last week that because of rising prices of foreign-made HIV/AIDS drugs, it would issue a five-year license to manufacture an inexpensive generic version of Merck & Co.'s Efavirenz drug. Though Merck -- which holds the ...
Morality and the fight against AIDS
CNN - Thailand made a surprise declaration that it was breaking the patent of an anti-retroviral drug to allow local and cheaper production of the HIV/AIDS drug Efavirenz. While the move does not break international law, it has sparked protests from U.S ...
Clinton announces price cut on HIV drugs for children
Aidsmap - In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine. The 45% average price reduction for the 19 formulations of these drugs ...
How the World Works
Salon - AIDS sufferers in Thailand are beginning to demonstrate resistance to the existing government-manufactured AIDS drug GPO-vir, but can't afford the high priced Efavirenz, marketed by Bristol-Myers Squibb under the name Sustiva. So in the interest of ...
FDA Approves Once-Daily Combo Drug for HIV
KXAN - The drug, called Atripla, combines Viread (tenofovir), Emtriva (emtricitabine) and Sustiva (efavirenz), to keep the human immunodeficiency virus under control. Viread and Emtriva are made by Gilead Sciences and are already sold in combination under ...
Bodily Changes Apparent After Nucleoside Analogue Therapy Switch
Medscape News - NEW YORK (Reuters Health) Sept 20 - Body composition improves in HIV patients, but metabolic profiles worsen after switching from a failed nucleoside analogue therapy to ritonavir-based indinavir and efavirenz, according to a report in the September ...
Want to contact a District of Columbia Sustiva lawyer? ...Get a free case evaluation from one of our District of Columbia Sustiva lawyers now.

Pages: Previous   1   2   3   4   5   6   7   8   9   Next

AddThis Social Bookmark Button

 

Need A Sustiva Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Sustiva Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Sustiva Case - Submit Your Information Below

Do you need legal assistance with your Sustiva case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Sustiva Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.